Ergomed is a specialist clinical research organization focused on rare disease and oncology trials, partnering with small to midsize biotech companies to move therapies through early phase development. With a collaborative international team across North America, South America, Europe, Asia and Australia, we value teamwork, flexibility, and work-life balance, fostering a culture where employees take ownership and grow their careers.
Perform review and analysis of centralized data to identify signals and trends in predefined risk indicators.
Support initial review of Risk Assessment and Categorization Tool (RACT) and conduct periodic reviews of site-level Key Risk Indicators (KRIs).
Monitor site performance, evaluate quality and integrity of study practices, and maintain effective project communication on centralized monitoring findings.